Ouzan D, Trépo C
Gastroenterol Clin Biol. 1986 Jan;10(1):53-6.
Viral replication was studied in 7 cases of PAN associated with hepatitis B virus (HBV). Serum and liver were strongly positive for markers reflecting HBV replication (constant high levels of HBe Ag, numerous hepatocytes nuclei reactive for HBc Ag, high DNA-polymerase activity). No cases were found to be positive for delta antigen or antibody. Mild biological and histological signs of liver damage were present in all patients but one. In PAN, high replication might lead to continuous stimulation and formation of circulating immune complexes in antigen excess which deposit in vascular walls with subsequent vasculitis. The demonstration of intense and permanent HBV replication could explain the unsatisfactory results observed with steroids and immunosuppressive drugs. Since steroids have been shown to increase HBV replication, this therapy might contribute to the perpetuation of the immunopathogenic process responsible for PAN. A more rational approach should take advantage of new antiviral drugs inhibiting HBV replication as suggested by preliminary beneficial results.
对7例与乙型肝炎病毒(HBV)相关的结节性多动脉炎(PAN)患者的病毒复制情况进行了研究。反映HBV复制的标志物在血清和肝脏中呈强阳性(持续高水平的HBe抗原、众多对HBc抗原呈反应性的肝细胞核、高DNA聚合酶活性)。未发现有病例的δ抗原或抗体呈阳性。除1例患者外,所有患者均有轻度的肝脏损害生物学和组织学征象。在PAN中,高复制可能导致持续刺激并在抗原过剩时形成循环免疫复合物,这些复合物沉积在血管壁,随后引发血管炎。强烈且持续的HBV复制的证实可以解释使用类固醇和免疫抑制药物所观察到的不理想结果。由于类固醇已被证明会增加HBV复制,这种治疗可能会导致导致PAN的免疫致病过程持续存在。正如初步有益结果所表明的那样,更合理的方法应该是利用抑制HBV复制的新型抗病毒药物。